Genetic analysis of hyperoxic acute lung injury survival in reciprocal intercross mice

Physiological Genomics

Volumn 30, Issue 3, 2007, Pages 271-281

  Prows, Daniel R ^a,b   Hafertepen, Amanda P ^b   Winterberg, Abby V ^b   Gibbons Jr , William J ^b   Liu, Chunyan ^b   Nick, Todd G ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acute respiratory distress syndrome; Imprinting; Quantitative trait locus analysis; Sex effect

Indexed keywords

OXYGEN;

ACUTE LUNG INJURY; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE INTERACTION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC EPISTASIS; GENETIC LINKAGE; HYPEROXIA; MALE; MOLECULAR IMPRINTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; QUANTITATIVE TRAIT LOCUS; SEGREGATION ANALYSIS; SEX DIFFERENCE; SURVIVAL TIME;

ANIMALS; CHROMOSOME MAPPING; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; HYPEROXIA; LINKAGE (GENETICS); MALE; MICE; MICE, INBRED C57BL; QUANTITATIVE TRAIT LOCI; RESPIRATORY DISTRESS SYNDROME, ADULT; SURVIVAL; SURVIVAL ANALYSIS;

ANIMALIA; MUS;

EID: 34548095723     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00038.2007     Document Type: Article

References (49)

1. Angus DC, Kelley MA, Schmitz RJ, White A, Popovich J Jr. Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population? JAMA 284: 2762-2770, 2000.
2. Bell RC, Coalson JJ, Smith JD, Johanson WG Jr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 99: 293-298, 1983.
3. Broman KW, Sen S, Owens SE, Manichaikul A, Southard-Smith EM, Churchill GA. The X chromosome in quantitative trait locus mapping. Genetics 174: 2151-2158, 2006.
4. Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890, 2003.
5. Brower RG, Ware LB, Berthiaume Y, Matthay MA. Treatment of ARDS. Chest 120: 1347-1367, 2001.
6. Cepkova M, Matthay MA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med 21: 119-143, 2006.
7. Cook DN, Wang S, Wang Y, Howles GP, Whitehead GS, Berman KG, Church TD, Frank BC, Gaspard RM, Yu Y, Quackenbush J, Schwartz DA. Genetic regulation of endotoxin-induced airway disease. Genomics 83: 961-969, 2004.
8. Fulkerson WJ, MacIntyre N, Stamler J, Crapo JD. Pathogenesis and treatment of the adult respiratory distress syndrome. Arch Intern Med 156: 29-38, 1996.
9. Goggel R, Winoto-Morbach S, Vielhaber G, Imai Y, Lindner K, Brade L, Brade H, Ehlers S, Slutsky AS, Schutze S, Gulbins E, Uhlig S. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Nat Med 10: 155-160, 2004.
10. Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC. Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 125: 203-211, 2004.
11. Grissom CK, Orme JF Jr, Richer LD, McIntyre TM, Zimmerman GA, Elstad MR. Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome. Crit Care Med 31: 770-775, 2003.
12. Haston CK, Zhou X, Gumbiner-Russo L, Irani R, Dejournett R, Gu X, Weil M, Amos CI, Travis EL. Universal and radiation-specific loci influence murine susceptibility to radiation-induced pulmonary fibrosis. Cancer Res 62: 3782-3788, 2002.
13. Holroyd KJ, Eleff SM, Zhang LY, Jakab GJ, Kleeberger SR. Genetic modeling of susceptibility to nitrogen dioxide-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 273: L595-L602, 1997.
14. Jain R, DalNogare A. Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin Proc 81: 205-212, 2006.
15. Kleeberger SR, Levitt RC, Zhang LY, Longphre M, Harkema J, Jedlicka A, Eleff SM, DiSilvestre D, Holroyd KJ. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice. Nat Genet 17: 475-478, 1997.
16. Kleeberger SR, Reddy S, Zhang LY, Jedlicka AE. Genetic susceptibility to ozone-induced lung hyperpermeability: role of toll-like receptor 4. Am J Respir Cell Mol Biol 22: 620-627, 2000.
17. Kollef MH, Schuster DP. The adult respiratory distress syndrome. N Engl J Med 332: 27-37, 1995.
18. Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U, Floros J. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 58: 181-191, 2000.
19. Mallakin A, Kutcher LW, McDowell SA, Kong S, Schuster R, Lentsch AB, Aronow BJ, Leikauf GD, Waltz SE. Gene expression profiles of Mst1r-deficient mice during nickel-induced acute lung injury. Am J Respir Cell Mol Biol 34: 15-27, 2006.
20. Manly KF, Cudmore RH Jr, Meer JM. Map Manager QTX, crossplatform software for genetic mapping. Mamm Genome 12: 930-932, 2001.
21. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 166: 646-650, 2002.
22. Moss M, Mannino DM. Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiplecause mortality data (1979 -1996). Crit Care Med 30: 1679-1685, 2002.
23. Ohtsuka Y, Clarke RW, Mitzner W, Brunson K, Jakab GJ, Kleeberger SR. Interstrain variation in murine susceptibility to inhaled acidcoated particles. Am J Physiol Lung Cell Mol Physiol 278: L469-L476, 2000.
24. Prows DR, Hafertepen AP, Gibbons WJ Jr, Winterberg AV, Nick TG. A genetic mouse model to investigate hyperoxic acute lung injury survival. Physiol Genomics (May 8, 2007). doi:10.1152/physiolgenomics.00232.2006.
25. Prows DR, Leikauf GD. Quantitative trait analysis of nickel-induced acute lung injury in mice. Am J Respir Cell Mol Biol 24: 740-746, 2001.
26. Prows DR, McDowell SA, Aronow BJ, Leikauf GD. Genetic susceptibility to nickel-induced acute lung injury. Chemosphere 51: 1139-1148, 2003.
27. Prows DR, Shertzer HG, Daly MJ, Sidman CL, Leikauf GD. Genetic analysis of ozone-induced acute lung injury in sensitive and resistant strains of mice. Nat Genet 17: 471-474, 1997.
28. Quasney MW, Waterer GW, Dahmer MK, Turner D, Zhang Q, Cantor RM, Wunderink RG. Intracellular adhesion molecule Gly241Arg polymorphism has no impact on ARDS or septic shock in community-acquired pneumonia. Chest 121: 85S-86S, 2002.
29. Qureshi ST, Zhang X, Aberg E, Bousette N, Giaid A, Shan P, Medzhitov RM, Lee PJ. Inducible activation of TLR4 confers resistance to hyperoxia-induced pulmonary apoptosis. J Immunol 176: 4950-4958, 2006.
30. Rubenfeld GD. Epidemiology of acute lung injury. Crit Care Med 31: S276-S284, 2003.
31. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 353: 1685-1693, 2005.
32. Seidenfeld JJ, Pohl DF, Bell RC, Harris GD, Johanson WG Jr. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 134: 12-16, 1986.
33. Sloane PJ, Gee MH, Gottlieb JE, Albertine KH, Peters SP, Burns JR, Machiedo G, Fish JE. A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rev Respir Dis 146: 419-426, 1992.
34. Suchyta MR, Clemmer TP, Elliott CG, Orme JF Jr, Weaver LK. The adult respiratory distress syndrome. A report of survival and modifying factors. Chest 101: 1074-1079, 1992.
35. Sue RD, Belperio JA, Burdick MD, Murray LA, Xue YY, Dy MC, Kwon JJ, Keane MP, Strieter RM. CXCR2 is critical to hyperoxia-induced lung injury. J Immunol 172: 3860-3868, 2004.
36. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, Archer SL. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112: 2477-2486, 2005.
37. Uhlig S, Goggel R, Engel S. Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung. Pharmacol Rep 57, Suppl: 206-221, 2005.
38. Villar J, Flores C, Mendez-Alvarez S. Genetic susceptibility to acute lung injury. Crit Care Med 31: S272-275, 2003.
39. Volkert MR, Elliott NA, Housman DE. Functional genomics reveals a family of eukaryotic oxidation protection genes. Proc Natl Acad Sci USA 97: 14530-14535, 2000.
40. Wang X, Ryter SW, Dai C, Tang ZL, Watkins SC, Yin XM, Song R, Choi AM. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J Biol Chem 278: 29184-29191, 2003.
41. Wang Y, Feinstein SI, Manevich Y, Ho YS, Fisher AB. Lung injury and mortality with hyperoxia are increased in peroxiredoxin 6 gene-targeted mice. Free Radic Biol Med 37: 1736-1743, 2004.
42. Wang Y, Phelan SA, Manevich Y, Feinstein SI, Fisher AB. Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. Am J Respir Cell Mol Biol 34: 481-486, 2006.
43. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
44. Wesselkamper SC, Chen LC, Gordon T. Quantitative trait analysis of the development of pulmonary tolerance to inhaled zinc oxide in mice. Respir Res 6: 73, 2005.
45. Wesselkamper SC, Prows DR, Biswas P, Willeke K, Bingham E, Leikauf GD. Genetic susceptibility to irritant-induced acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 279: L575-L582, 2000.
46. White P, Liebhaber SA, Cooke NE. 129X1/SvJ mouse strain has a novel defect in inflammatory cell recruitment. J Immunol 168: 869-874, 2002.
47. Yamada T, Iwasaki Y, Nagata K, Fushiki S, Nakamura H, Marunaka Y, Yodoi J. Thioredoxin-1 protects against hyperoxia-induced apoptosis in cells of the alveolar walls. Pulm Pharmacol Ther (September 1, 2006) doi:10.1016/jpupt.2006.07.004.
48. Zhang X, Shan P, Qureshi S, Homer R, Medzhitov R, Noble PW, Lee PJ. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol 175: 4834-4838, 2005.
49. Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med 157: 1159-1164, 1998.